---
document_datetime: 2025-10-02 11:58:34
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zynlonta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: zynlonta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.5458629
conversion_datetime: 2025-12-27 22:18:38.978358
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zynlonta

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                    |
|----------------------|----------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/11027 /202410  | Periodic Safety Update EU Single assessment - loncastuximab tesirine | 22/05/2025                          | 23/07/2025                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/11027/202410. |
| PSUSA/11027 /202404  | Periodic Safety Update EU Single assessment - loncastuximab tesirine | 28/11/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance                                                                                                          |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| R/0018    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                             | 19/09/2024   | 13/11/2024   |                 |                         |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------|-------------------------|
| IAIN/0020 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                              | 30/10/2024   | 23/07/2025   | Annex II and PL |                         |
| II/0015/G | for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range | 10/10/2024   | n/a          |                 | This was an application |
| IB/0019   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                           | 30/09/2024   | 23/07/2025   | SmPC            |                         |
| IB/0016/G | This was an application for a group of variations. B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting                   | 25/07/2024   | n/a          |                 |                         |

<div style=\"page-break-after: always\"></div>

|                     | material/intermediate B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                |            |     |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0014/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor | 21/05/2024 | n/a |                                   |
| PSUSA/11027 /202310 | Periodic Safety Update EU Single assessment - loncastuximab tesirine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 16/05/2024 | n/a | PRAC Recommendation - maintenance |
| IB/0012             | B.I.e.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                                                                                                                                                                                                                                                                                                                                                                                                  | 15/04/2024 | n/a |                                   |
| PSUSA/11027 /202304 | Periodic Safety Update EU Single assessment - loncastuximab tesirine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 30/11/2023 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| R/0009    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 14/09/2023   | 15/11/2023   | Annex II   |              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------|--------------|
| IB/0011/G | This was an application for a group of variations. B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.k - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - New storage site of MCB and/or WCB B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved | 18/09/2023   | n/a          |            | manufacturer |
| IB/0010/G | This was an application for a group of variations. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                  | 03/08/2023   | n/a          |            |              |
| IB/0007   | B.I.e.4.b - Changes to an approved change management protocol - Minor changes that do not change the strategy defined in the protocol                                                                                                                                                                                                                                                                                                                                                                                                | 11/07/2023   | n/a          |            |              |

<div style=\"page-break-after: always\"></div>

| IB/0006   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                 | 03/07/2023   | n/a        |                        |      |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|------|
| IB/0005   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time                                                                      | 08/05/2023   | n/a        |                        | data |
| IB/0004   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                              | 28/04/2023   | 15/11/2023 | SmPC                   |      |
| T/0002    | Transfer of Marketing Authorisation                                                                                                                                                                                                    | 25/01/2023   | 09/03/2023 | SmPC, Labelling and PL |      |
| IAIN/0003 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                     | 09/02/2023   | n/a        |                        |      |
| IAIN/0001 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 12/01/2023   | 09/03/2023 | SmPC, Annex II and PL  |      |